AU2016203713A1 — Solid compositions and methods for treating middle-of-the night insomnia
Assigned to Transcept Pharmaceuticals Inc · Expires 2016-06-23 · 10y expired
What this patent protects
SOLID COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF THE-NIGHT INSOMNIA The present invention provides compositions and methods for treating middle-of-the-night insomnia without residual sedative effects upon awakening by administering low doses (about 5 mg or less) of zolpidem …
USPTO Abstract
SOLID COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF THE-NIGHT INSOMNIA The present invention provides compositions and methods for treating middle-of-the-night insomnia without residual sedative effects upon awakening by administering low doses (about 5 mg or less) of zolpidem or a salt thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.